HK1038069A1 - Immunoassay for c.reactive protein - Google Patents

Immunoassay for c.reactive protein

Info

Publication number
HK1038069A1
HK1038069A1 HK01109045A HK01109045A HK1038069A1 HK 1038069 A1 HK1038069 A1 HK 1038069A1 HK 01109045 A HK01109045 A HK 01109045A HK 01109045 A HK01109045 A HK 01109045A HK 1038069 A1 HK1038069 A1 HK 1038069A1
Authority
HK
Hong Kong
Prior art keywords
immunoassay
antibody
antiidiotypic
reactive protein
monoclonal antibody
Prior art date
Application number
HK01109045A
Other languages
English (en)
Inventor
Edward R Scalice
John L Daiss
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Publication of HK1038069A1 publication Critical patent/HK1038069A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4737—C-reactive protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/965—Chemistry: molecular biology and microbiology involving idiotype or anti-idiotype antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK01109045A 2000-03-31 2001-12-24 Immunoassay for c.reactive protein HK1038069A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19395100P 2000-03-31 2000-03-31

Publications (1)

Publication Number Publication Date
HK1038069A1 true HK1038069A1 (en) 2002-03-01

Family

ID=22715702

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01109045A HK1038069A1 (en) 2000-03-31 2001-12-24 Immunoassay for c.reactive protein

Country Status (8)

Country Link
US (1) US6838250B2 (fr)
EP (1) EP1139101B1 (fr)
JP (1) JP5031148B2 (fr)
AT (1) ATE314653T1 (fr)
DE (1) DE60116172T2 (fr)
DK (1) DK1139101T3 (fr)
ES (1) ES2254330T3 (fr)
HK (1) HK1038069A1 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05005031A (es) 2002-11-12 2005-11-17 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
US20050136055A1 (en) 2003-12-22 2005-06-23 Pfizer Inc CD40 antibody formulation and methods
US20060154276A1 (en) 2004-05-13 2006-07-13 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
WO2006004039A1 (fr) * 2004-07-02 2006-01-12 Sanwa Kagaku Kenkyusho Co., Ltd. Appareil et procédé d'immunoessai
CA2605143A1 (fr) 2005-04-15 2006-10-26 Becton, Dickinson And Company Diagnostic d'une sepsie
US20060246522A1 (en) * 2005-04-28 2006-11-02 Bhullar Balwant S C-reactive protein immunoassay and method
CN101379399A (zh) * 2005-12-22 2009-03-04 罗姆股份有限公司 免疫测定装置和方法
US8383350B1 (en) 2006-12-20 2013-02-26 Merck Sharp & Dohme Corp. Assay for detection of IL-10 antibodies
US8969024B2 (en) * 2007-08-28 2015-03-03 Abbvie Biotechnology Ltd Compositions and methods comprising binding proteins for adalimumab
JP4970217B2 (ja) * 2007-11-07 2012-07-04 株式会社東芝 物質の測定方法
WO2009123737A2 (fr) 2008-04-03 2009-10-08 Becton, Dickinson And Company Détection avancée d'une sepsie
JP5265257B2 (ja) * 2008-06-30 2013-08-14 富士フイルム株式会社 犬ｃｒｐ及び人ｃｒｐを認識する抗体
CA2794757A1 (fr) 2008-11-11 2010-05-20 Prometheus Laboratories Inc. Procedes de prediction de maladie intestinale inflammatoire chronique (ibd) a l'aide de marqueurs serologiques
WO2010058860A1 (fr) * 2008-11-18 2010-05-27 株式会社シノテスト Procédé de mesure et réactif de mesure pour la protéine c-réactive dans un échantillon
WO2010120814A1 (fr) 2009-04-14 2010-10-21 Prometheus Laboratories Inc. Pronostics des maladies inflammatoires de l'intestin
ES2509616T3 (es) 2009-06-25 2014-10-17 Nestec S.A. Procedimientos de diagnóstico del síndrome del intestino irritable
WO2011060098A1 (fr) 2009-11-10 2011-05-19 Prometheus Laboratories Inc. Procédés de prévision de risque post-chirurgical associé à une anastomose iléo-anale avec poche
PT2569013T (pt) * 2010-05-14 2017-02-08 Univ Leland Stanford Junior Anticorpos monoclonais humanizados e quiméricos para cd47
SG189391A1 (en) 2010-10-18 2013-05-31 Nestec Sa Methods for determining anti-drug antibody isotypes
ES2530175T3 (es) 2011-02-17 2015-02-26 Nestec S.A. Ensayos para la detección de autoanticuerpos contra fármacos anti-TNF
MX2013012284A (es) 2011-04-29 2013-11-21 Bristol Myers Squibb Co Regimenes de elevacion de dosis del anticuerpo de proteina 10 inducible por interferon gamma (ip-10).
WO2012154987A1 (fr) 2011-05-10 2012-11-15 Nestec Sa Méthodes de profilage de l'activité d'une maladie pour une prise en charge thérapeutique personnalisée
MX352274B (es) 2011-10-21 2017-11-16 Nestec Sa Metodos para mejorar el diagnostico de enfermedad inflamatoria intestinal.
CA2861793C (fr) 2011-12-28 2023-08-01 Immunoqure Ag Methode pour fournir des auto-anticorps monoclonaux a specificite desiree
CN104838270A (zh) 2012-10-05 2015-08-12 雀巢产品技术援助有限公司 用于预测和监测粘膜愈合的方法
EP3004068A2 (fr) 2013-05-24 2016-04-13 Nestec S.A. Dosages spécifiques des voies de signalisation pour la prédiction de diagnostic du syndrome du côlon irritable
US10112995B2 (en) 2013-07-03 2018-10-30 Immunoqure Ag Human anti-IFN-α antibodies
JP6446044B2 (ja) 2013-11-05 2018-12-26 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 結合分子の存在下で被検体の総量および／または総濃度を決定するための方法、ならびにそれに関係するキット、組成物および使用
WO2015083087A1 (fr) 2013-12-03 2015-06-11 Nestec S.A. Procédés pour prédire la récurrence postopératoire de la maladie de crohn
WO2015166461A1 (fr) 2014-05-01 2015-11-05 Nestec S.A. Procédés de sélection de régime de traitement utilisant des niveaux de médicament de tnf alpha et d'anti-tnf alpha
JP2018504584A (ja) 2014-12-02 2018-02-15 ネステク ソシエテ アノニム 過敏性腸疾患患者を治療するためのベドリズマブの投与計画を確立する方法
CN108780088A (zh) 2015-11-06 2018-11-09 维蒂卡实验室公司 在伴侣动物中检测炎症标志物和治疗炎性病症的方法
CN108279229B (zh) * 2017-01-05 2024-02-27 深圳市帝迈生物技术有限公司 一种全血crp检测装置
AU2018349287A1 (en) 2017-10-10 2020-05-07 Prometheus Biosciences, Inc. Methods for monitoring vedolizumab treatment
CN112051403A (zh) * 2020-08-27 2020-12-08 武汉生之源生物科技股份有限公司 C反应蛋白化学发光免疫检测试剂盒及其制备方法和应用
EP4357778A1 (fr) 2022-10-20 2024-04-24 Heraeus Medical GmbH Traitement d'infections microbiennes diagnostiquées à l'aide du d-lactate de biomarqueur

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219730A (en) 1982-09-28 1993-06-15 New York University Idiotype-anti-idiotype immunoassay
US4828981A (en) 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
US4699880A (en) * 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
DE3685377D1 (de) * 1985-07-22 1992-06-25 Abbott Lab Fluoreszenz-polarisation-immunotest und reagens zur messung von c-reaktivem protein.
CA2057058C (fr) 1989-06-27 2000-09-05 Joan N. Siegel Anticorps monoclonaux contre les proteines c-reactives
JP3174402B2 (ja) * 1992-06-08 2001-06-11 三洋化成工業株式会社 競合法による免疫測定法および測定用キット
JPH10282098A (ja) * 1997-04-11 1998-10-23 Matsushita Electric Ind Co Ltd 蛍光免疫測定法

Also Published As

Publication number Publication date
EP1139101A3 (fr) 2002-05-15
US20020142356A1 (en) 2002-10-03
EP1139101A9 (fr) 2002-03-20
EP1139101A2 (fr) 2001-10-04
DE60116172D1 (de) 2006-02-02
ES2254330T3 (es) 2006-06-16
JP2002040024A (ja) 2002-02-06
ATE314653T1 (de) 2006-01-15
DE60116172T2 (de) 2006-08-03
US6838250B2 (en) 2005-01-04
DK1139101T3 (da) 2006-04-10
JP5031148B2 (ja) 2012-09-19
EP1139101B1 (fr) 2005-12-28

Similar Documents

Publication Publication Date Title
HK1038069A1 (en) Immunoassay for c.reactive protein
NZ547157A (en) Interferon Alpha Antibodies and their uses
RS50477B (sr) Anti-il-12 antitela, kompozicije, metode i njihove upotrebe
UA89017C2 (uk) ЛЮДСЬКЕ АНТИТІЛО, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ЛЮДСЬКИМ TNFSF13b
HK1045729A1 (en) Early detection of flavivviruses using the ns1 glycoprotein.
ATE384792T1 (de) Antikörpervarianten mit höheren bindungsaffinitäten im vergleich zu parentalen antikörpern
WO2003074679A3 (fr) Optimisation d'anticorps
EA200400510A1 (ru) Агенты, специфически связывающие ангиопоэтин-2
HK1078647A1 (en) Analytical sandwich test for determining nt-probnp
GB2383331A (en) Monoclonal antibody DS6 Tumor-associated antigen CA6 and methods of use thereof
WO2004025248A3 (fr) Methodes relatives a un dosage d'une paire d'anticorps
EP1378525A3 (fr) Anticorps humanisés qui se lient à l'antigène relié par l'anticorp NR-LU-13 et leur utilisation dans des méthodes de ciblage
HK1132750A1 (en) Monoclonal antibodies, cross-reactive antibodies and method for producing the same
DE602005026571D1 (de) Tumornekrosefaktor-alpha spezifische humanisierte antikörper
EP2186884A3 (fr) Anticorps monoclonaux contre des antigènes du noyau de CHV
WO1998023955A3 (fr) DETECTION D'IgM SPECIFIQUES D'ANTIGENES
WO2006015098A3 (fr) Immunodosage du taxol
DK1167389T3 (da) Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
NO20051715L (no) HCV assay
IL154000A (en) A method that uses antibodies to diagnose arthritis
IL108607A0 (en) Preparation of photoprotein conjugates and methods of use thereof
EP1326895B8 (fr) Anticorps monoclonaux diriges contre des virus de l'hepatite b
NO174153C (no) Antigen og monoklonalt antistoff for anvendelse in vitro, samt immunologiske reagenser inneholdende disse
WO2002076406A3 (fr) Anticorps contre autoantigenes de cirrhose biliaire primaire et methodes de preparation et d'utilisations associees
WO2002023202A3 (fr) Procede pour identifier des cibles d'anticorps therapeutiques associees a une reaction therapeutique

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100330